Within the Hospital segment, EQL Pharma markets medicines that are administered exclusively by healthcare professionals, such as injectable and infusion products.
These products are typically sold through public procurement systems, which may range from individual hospitals to nationwide contracts. Procurement frameworks vary considerably in terms of contract duration, exclusivity and product requirements. While price is generally the most important evaluation criterion, additional factors such as environmental impact and ease of use for healthcare professionals are increasingly being considered. The importance of these criteria has grown significantly in recent years.
Predictable Revenue Streams
One of the key advantages of the Hospital segment is that procurement contracts often extend over one or several years. This provides predictable revenue streams and makes production and supply planning relatively straightforward.
Hospital is a business area in which EQL closely monitors market developments and evolving customer requirements. A key priority for EQL is to identify and participate in the most attractive procurement opportunities, as contracts differ significantly in terms of duration, exclusivity and technical specifications.
Product examples
Ampitar
Caloket
Copneg